DAGA, MARTINA

DAGA, MARTINA  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 29 (tempo di esecuzione: 0.016 secondi).
Titolo Data di pubblicazione Autore(i) File
3D advanced human melanoma models 2017 Sorrentino, R; Squarzanti, Df; Dianzani, C; Cavalli, R; Cassoni, P; Annaratone, L; Ribero, S; Russo, R; Senetta, R; Daga, M; Barrera, G; Azzimonti, B; Pizzimenti, S
3D advanced melanoma models 2016 Azzimonti, Barbara; Landini, Manuela Miriam; Sorrentino, Rita; Dianzani, Chiara; Cavalli, Roberta; Castellano, Isabella; Annaratone, Laura; Ribero, Simone; Russo, Rosalia; Senetta, Rebecca; Daga, Martina; Barrera, Giuseppina; Pizzimenti, Stefania
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression 2019 Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 2019 Chiara Vigato, Agnese Chiara Pippione, Sandra Kovachka, Francesca Spyrakis, Martina Daga, Simonetta Oliaro Bosso, Marco Lucio Lolli, Donatella Boschi
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 2019 Chiara Vigato, Agnese Chiara Pippione, Sandra Kovachka, Francesca Spyrakis, Martina Daga, Simonetta Oliaro-Bosso, Marco Lucio Lolli, Donatella Boschi
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 2016 Pizzimenti, S.; Dianzani, C.; Zara, G.P.; Ferretti, C.; Rossi, F.; Gigliotti, C.L.; Daga, M.; Cianporcero, E.S.; Maina, G.; Barrera, G.
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 2018 Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina
DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity 2017 Gentile, Fabrizio; Arcaro, Alessia; Pizzimenti, Stefania; Daga, Martina; Cetrangolo, Giovanni Paolo; Dianzani, Chiara; Lepore, Alessio; Graf, Maria; Ames, Paul R J; Barrera, Giuseppina
Drug Delivery Nanoparticles in Skin Cancers 2014 Dianzani C; Zara GP; Maina G; Pettazzoni P; Pizzimenti S; Rossi F; Gigliotti CL; Ciamporcero ES; Daga M; Barrera G
Drug delivery nanoparticles in treating chemoresistant tumor cells 2017 Barrera, Giuseppina; Daga, Martina; Ferrara, Benedetta; Dianzani, Chiara; Pizzimenti, Stefania; Argenziano, Monica; Cavalli, Roberta; Trotta, Francesco
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity 2019 Santos A.R.N.; Sheldrake H.M.; Ibrahim A.I.M.; Danta C.C.; Bonanni D.; Daga M.; Oliaro-Bosso S.; Boschi D.; Lolli M.L.; Pors K.
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines 2015 Arcaro, Alessia; Daga, Martina; Cetrangolo, Giovanni Paolo; Ciamporcero, Eric Stefano; Lepore, Alessio; Pizzimenti, Stefania; Petrella, Claudia; Graf, Maria; Uchida, Koji; Mamone, Gianfranco; Ferranti, Pasquale; Ames, Paul R J; Palumbo, Giuseppe; Barrera, Giuseppina; Gentile, Fabrizio
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver 2020 Daga M.; de Graaf I.A.M.; Argenziano M.; Barranco A.S.M.; Loeck M.; Al-Adwi Y.; Cucci M.A.; Caldera F.; Trotta F.; Barrera G.; Casini A.; Cavalli R.; Pizzimenti S.
GSH-responsive nanoparticles in the treatment of tumor cells. 2015 Pizzimenti, Stefania; Daga, Martina; Ullio, Chiara; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Zara, Gian Paolo; Ferretti, Carlo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Barrera, Giuseppina .
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 2016 Daga, Martina; Ullio, Chiara; Argenziano, Monica; Dianzani, Chiara; Cavalli, Roberta; Trotta, Francesco; Ferretti, Carlo; Zara, Gian Paolo; Gigliotti, Casimiro L.; Ciamporcero, Eric S.; Pettazzoni, Piergiorgio; Corti, Denise; Pizzimenti, Stefania; Barrera, Giuseppina
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 2015 Pizzimenti, Stefania; Daga, Martina; Ciamporcero, Eric; Toaldo, Cristina; Pettazzoni, Piergiorgio; Osella-Abate, Simona; Novelli, Mauro; Minelli, Rosalba; Bisazza, Agnese; Gamba, Paola; Testa, Gabriella; Ullio, Chiara; Ferruti, Paolo; Ranucci, Elisabetta; Bernengo, Maria Grazia; Ferretti, Carlo; Dianzani, Chiara; Biasi, Fiorella; Barrera, Giuseppina; Cavalli, Roberta
In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research 2014 N. Steimberg; G. Mazzoleni; E.S. Ciamporcero; C. Ullio; M. Daga; G. Barrera; S. Pizzimenti
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 2013 Pizzimenti S; Ciamporcero E; Daga M; Pettazzoni P; Arcaro A; Cetrangolo G; Minelli R; Dianzani C; Lepore A; Gentile F; Barrera G.
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 2018 Antognelli, Cinzia*; Trapani, Eliana; Delle Monache, Simona; Perrelli, Andrea; Daga, Martina; Pizzimenti, Stefania; Barrera, Giuseppina; Cassoni, Paola; Angelucci, Adriano; Trabalzini, Lorenza; Talesa, Vincenzo Nicola; Goitre, Luca; Retta, Saverio Francesco
Latest News on Nanotechnology for Melanoma Therapy and Diagnosis 2016 Daga, Martina; Dianzani, Chiara; Ferrara, Benedetta; Nardozza, Valeria; Cavalli, Roberta; Barrera, Giuseppina; Pizzimenti, Stefania